Search results for "102"

showing 10 items of 2892 documents

Intravenöse Eisensubstitution bei chronischer Erkrankung – bei wem, wann und wie?

2019

ZusammenfassungIn den letzten Jahren konnten wesentliche Fortschritte in der Erkennung und Behandlung des Eisenmangels erzielt werden, deren Ergebnisse auch für viele Fachgebiete und insbesondere mit Patienten mit chronisch-entzündlichen Erkrankungen relevant sind. Allerdings wird in der täglichen Praxis ein Eisenmangel vielfach nicht identifiziert und konsequent therapiert.Ein Eisenmangel kann – auch bevor eine Anämie auftritt – die Lebensqualität einschränken und den Verlauf der Grunderkrankung beeinflussen. Bei Patienten mit chronischen Erkrankungen sollte der Eisenstatus regelmäßig erfasst werden. Gerade bei Patienten mit chronisch-entzündlichen Erkrankungen sind die derzeit verfügbaren…

medicine.medical_specialtyIron uptakebusiness.industryAnemiaIRON PREPARATIONS030232 urology & nephrology10265 Clinic for Endocrinology and Diabetology610 Medicine & healthGeneral MedicineIron deficiency2700 General Medicine030204 cardiovascular system & hematologymedicine.diseaseEnteral administrationGastroenterology03 medical and health sciences0302 clinical medicineTolerabilityQuality of lifeInternal medicinemedicineIn patientbusiness
researchProduct

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic ha…

2021

BACKGROUND: Cytomegalovirus (CMV) is a complication of allogeneic haematopoietic cell transplantation (allo-HCT). ASP0113, a DNA-based vaccine, contains two plasmids encoding human CMV glycoprotein B and phosphoprotein 65 (pp65). We assessed ASP0113 in CMV-seropositive allo-HCT recipients. METHODS: In this phase 3, randomised, placebo-controlled study, CMV-seropositive allo-HCT recipients were randomly assigned (1:1) via interactive response technology to receive five injections of 1 mL of 5 mg/mL ASP0113 or placebo. The pharmacist and designated staff were unblinded. Masked syringes maintained the blind for patients and study personnel. Efficacy and safety analyses included patients who re…

medicine.medical_specialtyPhases of clinical research[SDV.CAN]Life Sciences [q-bio]/CancerDiseaseGANCICLOVIRPlacebo01 natural sciencesPROPHYLAXIS03 medical and health sciencesDOUBLE-BLIND0302 clinical medicineMedicine General & Internal[SDV.CAN] Life Sciences [q-bio]/CancerInternal medicineGeneral & Internal MedicinemedicineCYTOMEGALOVIRUS DISEASE030212 general & internal medicine0101 mathematicsAdverse effectlcsh:R5-920Science & Technologybusiness.industryIncidence (epidemiology)010102 general mathematicsGeneral MedicineOdds ratioConfidence interval3. Good healthbusinessComplicationlcsh:Medicine (General)Life Sciences & BiomedicineResearch PaperEClinicalMedicine
researchProduct

Evaluation of Shared Genetic Susceptibility to High and Low Myopia and Hyperopia

2021

Importance: Uncertainty currently exists about whether the same genetic variants are associated with susceptibility to low myopia (LM) and high myopia (HM) and to myopia and hyperopia. Addressing this question is fundamental to understanding the genetics of refractive error and has clinical relevance for genotype-based prediction of children at risk for HM and for identification of new therapeutic targets. Objective: To assess whether a common set of genetic variants are associated with susceptibility to HM, LM, and hyperopia. Design, Setting, and Participants: This genetic association study assessed unrelated UK Biobank participants 40 to 69 years of age of European and Asian ancestry. Par…

medicine.medical_specialtyRefractive errorgenetic structuresEmmetropiaGenome-wide association study01 natural sciences03 medical and health sciences0302 clinical medicineInternal medicinemedicineGenetic predispositionMyopiaHumansGenetic Predisposition to Disease0101 mathematicsAlleleChildGenetic associationOriginal Investigationbusiness.industry010102 general mathematicsOdds ratioHeritabilitymedicine.diseaseRefractive Errorseye diseases3. Good healthOphthalmologyHyperopia030221 ophthalmology & optometrybusinessGenome-Wide Association StudyJAMA Ophthalmology
researchProduct

Three-Year Results of Hydrus Microstent with Phacoemulsification

2019

Abstract We report the 3-year IOP efficacy of the implantation of the Schlemm’s canal Hydrus® Microstent (Ivantis®) combined with phacoemulsification versus phacoemulsification alone

medicine.medical_specialtyTime Factorsgenetic structuresmedicine.medical_treatmentGlaucoma01 natural sciencesCataract03 medical and health sciences0302 clinical medicineOphthalmologymedicineHumansSingle-Blind MethodProspective Studies0101 mathematicsGlaucoma Drainage ImplantsMiniaturizationPhacoemulsificationbusiness.industry010102 general mathematicsGlaucomaGeneral MedicinePhacoemulsificationmedicine.diseaseeye diseasesTreatment Outcome030221 ophthalmology & optometryStentssense organsbusinessFollow-Up Studies
researchProduct

Diagnosis and Treatment of Lower Extremity Venous Thromboembolism

2020

Importance: Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to 112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from 20% to 36% during the 10 years after an initial event.Observations: PubMed and Cochrane databases were searched for English-language studies published from January 2015 through June 2020 for randomized clinical trials, meta-analyses, systematic reviews, and observational studies. Risk factors for venous thromboembolism (VTE), such as older age, malignancy (cumulative incidence of 7.4% after a median of 19 months), inflammatory disorders (VTE risk is 4.7% in patients with rheumatoid arthritis and 2.5% in those withou…

medicine.medical_specialtyVena Cava FiltersDeep vein01 natural sciencesPostthrombotic Syndromelaw.inventionFibrin Fibrinogen Degradation Products03 medical and health sciencesSex Factors0302 clinical medicineRandomized controlled trialPredictive Value of TestsRisk FactorslawInternal medicineMedical IllustrationFactor V LeidenHumansThrombophiliaMedicineCumulative incidencecardiovascular diseases030212 general & internal medicine0101 mathematicsLife StyleThrombectomyUltrasonographybusiness.industry010102 general mathematicsAge FactorsWarfarinVenous ThromboembolismGeneral Medicinemedicine.diseaseThrombosisPre- and post-test probabilitymedicine.anatomical_structureLower ExtremityPredictive value of testsWarfarinSymptom AssessmentbusinessBiomarkersFactor Xa Inhibitorsmedicine.drugJAMA
researchProduct

Isolation and confirmation of viral nervous necrosis (VNN) disease in golden grey mullet (Liza aurata) and leaping mullet (Liza saliens) in the Irani…

2016

The present study was conducted on 428 moribund mullet fish samples to isolate and identify the causative agent of a mysterious acute mortality which recently occurred in wild mullets in Iranian waters of Caspian Sea, suspected to be due to viral nervous necrosis (VNN) disease. Disease investigation was carried out employing various diagnostic procedures such as virology, bacteriology, parasitology, haematology, histopathology, IFAT, IHC and nested RT-PCR. Brain and eye samples of affected fishes were collected in sterile conditions and then kept at -80 °C for cell culture isolation and nested RT-PCR detection of the causative agent. Other tissue samples were also collected and fixed for hi…

medicine.medical_specialtyVeterinary medicinePathology040301 veterinary sciencesCaspian sea; Golden grey mullet (Liza aurata); Iran; Leaping mullet (Liza saliens); Viral nervous necrosisOceans and SeasViral nervous necrosisBetanodavirusSettore BIO/05 - ZoologiaBiologyIranMicrobiologyPolymerase Chain ReactionMulletCell Line0403 veterinary scienceTissue cultureFish DiseasesRNA Virus InfectionsMicroscopy Electron TransmissionmedicineCaspian seaAnimalsNodaviridaeFluorescent Antibody Technique IndirectGeneral VeterinaryOutbreak04 agricultural and veterinary sciencesGeneral Medicinebiology.organism_classificationImmunohistochemistrySurvival AnalysisSmegmamorphaParasitology040102 fisheries0401 agriculture forestry and fisheriesHistopathologyGolden grey mullet (Liza aurata)Leaping mullet (Liza saliens)Golden grey mulletLeaping mulletVeterinary microbiology
researchProduct

Medical evaluation of athletes: Exercise testing

2020

Exercise testing in athletes is used to (a) evaluate baseline fitness and prescribe an exercise program or training zones, (b) evaluate continued progress after engaging in exercise training over a period of time, (c) diagnose cardiopulmonary conditions affecting exercise performance, and, (d) provoke arrhythmias or evaluate hemodynamic response to exercise in an athlete with a known cardiovascular condition to determine whether it is safe to participate in competitive sports. Exercise testing is not part of routine pre-participation (PPS) screening; however, it can supplement the clinical work-up of athletes with pathological findings during PPS and/or with symptoms. In several conditions …

medicine.medical_specialtybiologyAthletesbusiness.industryMedical evaluation610 Medicine & healthmedicine.diseasebiology.organism_classificationSudden cardiac deathExercise programExercise performancePhysical therapymedicine10209 Clinic for Cardiologybusiness
researchProduct

Do we know more about hypertension in Poland after the May Measurement Month 2017?—Europe

2019

Abstract Elevated blood pressure (BP) is a worldwide burden, leading to over 10 million deaths yearly. May Measurement Month (MMM) is a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for BP screening. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May 2017. BP measurement, the definition of hypertension and statistical analysis followed the globally approved MMM17 Study Protocol. In Poland 5834 (98.9%, Caucasian) individuals were screened. After multiple imputation, 2601 (35.3%) had hypertension. Of individuals not receiving anti-hypertensive medication, 976 (20.6%) were hype…

medicine.medical_specialtybusiness.industryArticles030204 cardiovascular system & hematologyOverweightmedicine.diseaseObesityElevated blood03 medical and health sciences0302 clinical medicineBlood pressureCardiovascular System & HematologyInternal medicinemedicineStatistical analysis030212 general & internal medicineSystoleUnderweightmedicine.symptomCardiology and Cardiovascular Medicinebusiness1102 Cardiorespiratory Medicine and HaematologyOpportunistic screeningEuropean Heart Journal Supplements
researchProduct

Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simula…

2020

Omar S Usmani,1 Nicola Scichilone,2 Benjamin Mignot,3 Dennis Belmans,3 Cedric Van Holsbeke,3 Jan De Backer,3 Roberta De Maria,4 Erika Cuoghi,4 Eva Topole,4 George Georges4 1Airway Disease Section, National Heart and Lung Institute, Imperial College, London, UK; 2PROMISE Department of Medicine, University of Palermo, Palermo, Italy; 3FLUIDDA, Kontich, Belgium; 4Chiesi Farmaceutici, SpA, Parma, ItalyCorrespondence: George GeorgesChiesi USA Inc., 175 Regency Woods Place, Ste. 600, Cary, NC 27518, USATel +1 (919) 678 6611 x1536Email george.georges@chiesi.comIntroduction: There is a clear correlation between small airways dysfunction and poor clinical outcomes in patients with chronic obstructiv…

medicine.medical_specialtymedicine.drug_classRespiratory SystemUrologyInternational Journal of Chronic Obstructive Pulmonary DiseaseSettore MED/10 - Malattie Dell'Apparato RespiratoriotomographyDry powder inhalers Inhaled corticosteroid Long-acting beta2 agonist Long-acting muscarinic antagonist Metered dose inhalers Tomography X-ray computedinhaled corticosteroidFluticasone propionatePulmonary Disease Chronic Obstructivechemistry.chemical_compoundFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumanslong-acting muscarinic antagonistComputer SimulationGlycopyrronium bromideRespiratory systemmetered dose inhalers1102 Cardiorespiratory Medicine and HaematologyOriginal Researchx-ray computedlcsh:RC705-779COPDScience & TechnologyInhalationbusiness.industrydry powder inhalersGeneral Medicinelcsh:Diseases of the respiratory systemrespiratory systemmedicine.diseaseBronchodilator AgentsDrug CombinationschemistryCorticosteroidVilanterolbusinessLife Sciences & Biomedicinelong-acting beta2 agonistmedicine.drugInternational Journal of COPD
researchProduct

Differential of metric valued Sobolev maps

2020

We introduce a notion of differential of a Sobolev map between metric spaces. The differential is given in the framework of tangent and cotangent modules of metric measure spaces, developed by the first author. We prove that our notion is consistent with Kirchheim's metric differential when the source is a Euclidean space, and with the abstract differential provided by the first author when the target is $\mathbb{R}$.

metric measure spacesPure mathematicsFunction spaces; Metric measure spaces; Sobolev spaces01 natural sciencesMetric measure spacesfunction spacesSettore MAT/05 - Analisi Matematica0103 physical sciencesFOS: MathematicsTrigonometric functions0101 mathematicsMathematicsEuclidean space010102 general mathematicsTangentmetriset avaruudetFunctional Analysis (math.FA)Mathematics - Functional AnalysisSobolev spaceMetric spaceSobolev spacesFunction spaces010307 mathematical physicsfunktionaalianalyysiMetric differentialAnalysisJournal of Functional Analysis
researchProduct